Conjoint Prof Ingrid van Beek AM
Independent Chair of the Board
Dr Ingrid van Beek AM is a public health and addiction medicine physician who has been working at the sharp end of harm reduction for more than 30 years.
Prof Jacqueline Bowden – NCETA
Consortium Member
Professor Jacqueline Bowden is Director of the National Centre for Education and Training on Addiction (NCETA), Flinders University.
Prof Michael Farrell – NDARC
Consortium Member
Professor Michael Farrell FRCP FRCPsych is the Director of the National Drug and Alcohol Research Centre (NDARC) at the University of New South Wales.
Prof Simon Lenton – NDRI
Consortium Member
Professor Simon Lenton is Director of the National Drug Research Institute (NDRI) at Curtin University, where he has worked since 1993.
Prof Adrian Dunlop – HNELHD
Advisory Board Member
Professor Adrian Dunlop has over 24 years experience as an addiction clinician and clinician/researcher. He currently serves as the Director and Addiction Medicine Senior Staff Specialist with Hunter New England Local Health District, Drug & Alcohol Clinical Services (2007-current).
Prof Nick Lintzeris – DACRIN
Advisory Board Member
Conjoint Professor Nicholas (Nick) Lintzeris is an Addiction Medicine specialist who has been involved for over two decades in clinical service delivery, research, professional education and policy activities in the field.
Dr Annalee Stearne – NDRI
Advisory Board Member
Annalee Stearne, a Nyungar from WA, has been working in Curtin University’s National Drug Research Institute since 2001.
Steph Tzanetis – Penington Institute and CAHMA/CanTEST
Advisory Board Member
Steph Tzanetis is the workforce development lead at Penington Institute.
A/Prof Gillinder Bedi
Board Member
A/Prof Gillinder Bedi is Head of Substance Use Research at Orygen and Principal Research Fellow (Addiction and Youth Mental Health) at the Centre for Youth Mental Health at the University of Melbourne.
Baillee Farah
Board Member
Baillee Farah is an advocate and early career researcher working towards more equitable and beneficial health policy and practice, with a focus on alcohol and other drugs.